We are dedicated to improving human health by unlocking the power of the genome. A global leader in dna sequencing and arraybased technologies, illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. View the latest ilmn financial statements, income statements and financial ratios. In 2015 we published the paper that accompanies the neurox genotyping array, a tool that was born from the collaborative efforts of several dozen researchers and illumina. Beginning at the genetic level, illumina tools are used to elucidate the. Illumina reports financial results for third quarter of. The company expects revenue growth of 20% and nongaap earnings. Illumina reports full financial results for fourth quarter. As of january 16, 2020, we owned or had exclusive licenses to 799. View all ilmn assets, cash, debt, liabilities, shareholder equity and investments. Section 16a beneficial ownership reporting compliance.
Ilmn sec filing 10k annual report for the fiscal year ending sunday, december 29, 2019. Find out the revenue, expenses and profit or loss over the last fiscal year. Get the detailed quarterlyannual income statement for illumina, inc. Looking ahead illumina also confirmed guidance for the 2015 fiscal year that was initially provided during the jp morgan conference. Headquarter relocation for fiscal 2012 and fiscal 2011 consisted of ceaseuse. Annual reports investor relations incyte corporation. Companys projected annual instrument utilization 3. A global leader in dna sequencing and arraybased technologies, illumina is fueling. Illumina reports financial results for first quarter of fiscal year 2020. Shares of the genomic sequencing company were down 17% year to date. Illumina reports financial results for fourth quarter and fiscal year 2019. Illumina investor relations source book april 2019 2 this source book is intended to pull together information to help you learn about illumina s product offering, strategy and historic performance. Tb equivalent to 16 human genomes of genomic data in a single run. Annual report pursuant to section or 15d of the securities.
This annual report on form 10k contains, and our officers and. Get the latest full company report for illumina inc from zacks investment research. This annual report on form 10k contains forwardlooking statements. In 2015, we continued to increase our manufacturing capacity to meet customer demand. Export annual and quarterly reports to adobe pdf, microsoft word and excel for offline viewing, annotations and analysis. Illumina incilmn annual report 10k quarterly report 10q.
1401 32 737 920 1239 100 96 89 610 1254 46 557 328 866 1164 98 820 974 46 1487 705 1426 299 476 825 148 1109 1166 25